BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 14576773)

  • 1. Restoration of sensitivity to anoikis in Ras-transformed rat intestinal epithelial cells by a Ras inhibitor.
    Shalom-Feuerstein R; Lindenboim L; Stein R; Cox AD; Kloog Y
    Cell Death Differ; 2004 Feb; 11(2):244-7. PubMed ID: 14576773
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of the Ras oncoprotein reduces proliferation of hepatocytes in vitro and in vivo in rats.
    da Silva Morais A; Saliez A; Leclercq I; Horsmans Y; Stärkel P
    Clin Sci (Lond); 2008 Jan; 114(1):73-83. PubMed ID: 17678500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressor protein kinase Chk2 is a mediator of anoikis of intestinal epithelial cells.
    Yoo BH; Berezkin A; Wang Y; Zagryazhskaya A; Rosen KV
    Int J Cancer; 2012 Jul; 131(2):357-66. PubMed ID: 21834075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras inhibition increases the frequency and function of regulatory T cells and attenuates type-1 diabetes in non-obese diabetic mice.
    Mor A; Kloog Y; Keren G; George J
    Eur J Pharmacol; 2009 Aug; 616(1-3):301-5. PubMed ID: 19527709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of apicidin, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H; Im JY; Kim J; Choi WS; Kim HS
    Int J Mol Med; 2008 Mar; 21(3):325-33. PubMed ID: 18288380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New derivatives of farnesylthiosalicylic acid (salirasib) for cancer treatment: farnesylthiosalicylamide inhibits tumor growth in nude mice models.
    Goldberg L; Haklai R; Bauer V; Heiss A; Kloog Y
    J Med Chem; 2009 Jan; 52(1):197-205. PubMed ID: 19072665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The farnesyltransferase inhibitor, LB42708, inhibits growth and induces apoptosis irreversibly in H-ras and K-ras-transformed rat intestinal epithelial cells.
    Kim HS; Kim JW; Gang J; Wen J; Koh SS; Koh JS; Chung HH; Song SY
    Toxicol Appl Pharmacol; 2006 Sep; 215(3):317-29. PubMed ID: 16712893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of the transformed phenotype and inhibition of peptidylglycine alpha-monooxygenase in Ras-transformed cells by 4-phenyl-3-butenoic acid.
    Sunman JA; Foster MS; Folse SL; May SW; Matesic DF
    Mol Carcinog; 2004 Dec; 41(4):231-46. PubMed ID: 15468302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Farnesylthiosalicylic acid induces caspase activation and apoptosis in glioblastoma cells.
    Amos S; Redpath GT; Polar G; McPheson R; Schiff D; Hussaini IM
    Cell Death Differ; 2006 Apr; 13(4):642-51. PubMed ID: 16239932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cells.
    Mor A; Keren G; Kloog Y; George J
    Eur J Immunol; 2008 Jun; 38(6):1493-502. PubMed ID: 18461565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
    Huber MA; Azoitei N; Baumann B; Grünert S; Sommer A; Pehamberger H; Kraut N; Beug H; Wirth T
    J Clin Invest; 2004 Aug; 114(4):569-81. PubMed ID: 15314694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of intimal thickening in the rat carotid artery injury model by a nontoxic Ras inhibitor.
    George J; Sack J; Barshack I; Keren P; Goldberg I; Haklai R; Elad-Sfadia G; Kloog Y; Keren G
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):363-8. PubMed ID: 14670932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate-induced polarisation of cultured epitheliocytes and fibroblasts: non-reactivity of Ras-transformed cells.
    Moizhess TG; Vasiliev JM
    Cell Biol Int; 2001; 25(9):931-4. PubMed ID: 11518500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandins and activation of AC/cAMP prevents anoikis in IEC-18.
    Joseph RR; Yazer E; Hanakawa Y; Stadnyk AW
    Apoptosis; 2005 Dec; 10(6):1221-33. PubMed ID: 16215681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Getting at MYC through RAS.
    Bachireddy P; Bendapudi PK; Felsher DW
    Clin Cancer Res; 2005 Jun; 11(12):4278-81. PubMed ID: 15958607
    [No Abstract]   [Full Text] [Related]  

  • 16. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
    Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
    Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ha-Ras sensitizes transformed mouse skin cells to Anisomycin-induced apoptosis.
    Santibañez JF; Hurtado C
    FEBS Lett; 2005 Nov; 579(28):6459-64. PubMed ID: 16288745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways.
    Shapira S; Barkan B; Friedman E; Kloog Y; Stein R
    Cell Death Differ; 2007 May; 14(5):895-906. PubMed ID: 17096025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
    Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
    Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for cyclic-GMP dependent protein kinase in anoikis.
    Hou Y; Wong E; Martin J; Schoenlein PV; Dostmann WR; Browning DD
    Cell Signal; 2006 Jun; 18(6):882-8. PubMed ID: 16139477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.